Chicago, IL, United States of America

Michael Kirisits


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Michael Kirisits in Antimicrobial Agents

Introduction

Michael Kirisits, based in Chicago, IL, is an accomplished inventor with a significant contribution to the field of antimicrobial agents. With one patent to his name, he has made strides in utilizing unique components from Apicomplexan parasites to develop diagnostic reagents and vaccines.

Latest Patents

Kirisits’ patent, titled "Antimicrobial agents, diagnostic reagents, and vaccines based on unique Apicomplexan parasite components," delves into the use of chorismate synthase, a crucial component of plant-like metabolic pathways. This invention is particularly noteworthy as it focuses on elements not typically operative in animals or encoded by plastid DNA. The patent describes assays for developing compositions that impair Apicomplexan growth and survival. It highlights various components of plant-like pathways, including enzymes, transit peptides, and nucleotide sequences necessary for these biological functions.

Career Highlights

Michael Kirisits works at Apicomplexan Therapeutics, LLC, where he applies his expertise in microbiology and molecular biology. His innovative approaches have garnered attention in both academic and commercial sectors, pushing boundaries in the development of therapeutic reagents and vaccines aimed at combating diseases caused by Apicomplexan parasites.

Collaborations

Throughout his career, Kirisits has collaborated with prominent individuals in the field, including Rima McLeod and Craig Roberts. These collaborations have fostered advancements in research and applications in antimicrobial development, enriching the potential impact of their work on public health.

Conclusion

Michael Kirisits stands out as a significant figure in the field of antimicrobial research. His innovative patent and collaborative efforts at Apicomplexan Therapeutics, LLC have the potential to transform how diseases caused by Apicomplexan parasites are diagnosed and treated. As research continues, Kirisits’ contributions will undoubtedly play a critical role in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…